Tilaknagar Inds.

Q1 FY27Beverages

Tilaknagar Inds. Q1 FY27 Results & Concall Highlights: Revenue, Margins & Order Book

Q1 FY27 earnings call: what management guided on revenue, margins and order book.

Price₹574

Market cap₹14.2K Cr

P/E63.0

Updated25 Aug 2026

Read4 min read

What the Q1 FY27 call signalled

2 of 3 strong

RevenueRank 3

MarginRank 1

CapexYes

Not discussed on this call: fundraise, order book.

The short version

FY27 guidance: High single-digit to low double-digit volume growth for the combined business (Tilaknagar + Imperial Blue). Tilaknagar Industries expects high single-digit to low double-digit volume growth for FY27, upgrading to mid-teen annual volume growth over the next couple of years (FY28 onwards).

From Tilaknagar Inds.'s Q1 FY27 earnings-call transcript · updated 25 Aug 2026.

Revenue & Sales Performance

Rank 3

FY27 guidance: High single-digit to low double-digit volume growth for the combined business (Tilaknagar + Imperial Blue).
Post-FY27: Expect annual volume growth in mid-teens over the next couple of years.
Revenue growth is expected to be ~300 basis points higher than volume growth.
EBITDA margins for the combined business targeted at 16%-18% by FY29, with an upward bias.
New product launches planned from FY28 onwards to drive mid-double-digit volume growth and revenue CAGR of mid-teens till FY29.
Focus on expanding the premium and luxury portfolio leveraging pan-India distribution network.
Imperial Blue volume expected to register double-digit growth for the full year.
Market share gains across states and increasing width and depth of distribution remain key growth drivers.

Profitability & Margins

Tilaknagar Industries expects high single-digit to low double-digit volume growth for FY27, upgrading to mid-teen annual volume growth over the next couple of years (FY28 onwards).
Revenue growth is projected to outpace volume growth by approximately 300 basis points.
Consolidated EBITDA margins are targeted to reach 16%-18% by FY29, with an upward bias.
The company aims to improve upon the baseline 15.5% EBITDA margin achieved in Q4 FY26, despite inflationary pressures.
Net debt-to-EBITDA ratio is expected to fall below 1.0x by March FY29, reflecting disciplined debt management.
EBITDA margin expansion of approximately 250 basis points is anticipated on the Imperial Blue combined business through supply chain optimization and price increases.
PAT grew by 52% in Q1 FY27 but excluding inflation and subsidy impacts, EBITDA margins were closer to 17%.
New premium launches from FY28 onwards are expected to further drive mid-double-digit volume growth and margin expansion.

See what Tilaknagar Inds. said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Yes

Tilaknagar doubled down on its investment in Bartisans, increasing its stake from 36.2% to 41.5%.
The proceeds from this strategic investment in Bartisans will be used to expand within the quick commerce segment, focus on product and packaging innovation, and support collaborative launches with Tilaknagar Industries.
No other specific current or future capital expenditure (capex) plans were mentioned in the transcript for the near term.
The focus remains on integration of Imperial Blue and growing existing business volumes, expanding distribution, and launching new premium products rather than significant new capex.

Top-ranked in Beverages

Ranked on what management guided this quarter

5x potential

1Varun Beverages₹1.4L Cr

Rev 2Mar 3

2Fratelli Vineyards Ltd₹565 Cr

Rev 2Mar 3

3₹17.7K Cr

Rev 3Mar 1

4₹33.2K Cr

Rev 3Mar 3

5₹1.5K Cr

Rev 3Mar 3

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

The company currently has a term debt of approximately Rs. 2,000 crore, with a structured repayment where about 80% of payments are due in years 5 and 6, providing cushioning with a moratorium for the first 2 years.
As of Q1 FY27, net debt stands at Rs. 2,100 crore.
The company has a clear target to reduce net debt to around Rs. 1,700 crore by March 31, FY27, indicating no immediate plans to raise additional debt.
Focus is on disciplined debt management and working capital investments to reduce net debt-to-EBITDA ratio below 1.0x by FY29.
There was no explicit mention of any current or planned new fundraising through equity in the disclosed conference call or transcript.

See what Tilaknagar Inds. said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The transcript provided does not explicitly mention current or expected order book or pending orders for Tilaknagar Industries. However, related insights include: - The company is focused on the successful integration of the Imperial Blue business, which was completed rapidly within 4 months. - There is emphasis on expanding distribution, especially for Imperial Blue and the premium/luxury portfolio. - The business is targeting double-digit volume growth for the combined entity in FY27, with mid-teens CAGR volumes expected over the next couple of years. - New launches planned from FY28 onwards suggest a pipeline of future products contributing to order demand. - Working capital cycle investment has increased net debt, indicating operational scale-up but no specific order backlog is quantified. No direct details on order book or pending orders are provided in the transcript.

Tilaknagar Inds. — Quarterly revenue & net profit

Revenue Net profit Net loss

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Reported quarterly figures (₹ Cr). Latest: revenue ₹664 Cr, net loss ₹105 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What Tilaknagar Industries Ltd's management said in earlier quarters

Others in Beverages this season

India Glycols Ltd (Q1 FY27)
For the NSU (Nutraceuticals and Specialty Units) segment, the planned capex for the current year is modest, approximately INR 5-20 crores, focusing on…
BCL Industries Ltd (Q1 FY27)
Supreme Court's allowance for OMCs to procure 1.49 billion liters for Q4 FY25-'26 could add incremental volume (~4.5 crore liters) for the company in next 2-3…
India Glycols Ltd (Q1 FY27)
Chemicals business shows 25% YoY revenue growth; pipeline strong in performance chemicals. Key concall takeaways from India Glycols Ltd's Q1 FY27 earnings call…
Globus Spirits Ltd (Q1 FY27)
Capacity utilization, especially the UP plant (~25% captive utilization, rest bulk sales with month-to-month optimization). Key concall takeaways from Globus…

Compare:vs Varun Beverages Ltd vs Radico Khaitan vs United Breweries Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Tilaknagar Inds. Q1 FY27 results?

What is Tilaknagar Inds. share price analysis?

Tilaknagar Inds. currently shows a below-average growth signal. The stock trades at a P/E of 63.0 with a market cap of ₹14,246 Cr. Investors should review the full earnings analysis for detailed insights.

Is Tilaknagar Inds. planning capital expenditure?

Tilaknagar doubled down on its investment in Bartisans, increasing its stake from 36.2% to 41.5%.

Keep Tilaknagar Inds. on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.